Skip to content

The Canadian Journal of Psychiatry

ISSN 0706-7437

16 papers in the library · 1,430 citations · publishing 1980-2026

Papers

Sort Most recent Most cited

Cannabis Use Interacts With Psychosis Vulnerability in Borderline Personality Disorder: La consommation de cannabis interagit avec la vulnérabilité à la psychose dans le trouble de la personnalité limite

The Canadian Journal of Psychiatry September 11, 2026 James Mirabelli, James MacKillop, David Streiner et al.

Background Individuals with borderline personality disorder (BPD) frequently use cannabis, often for self-medication. However, cannabis use has also been linked to BPD symptom severity, suggesting heterogeneity in its effects. Individuals with BPD frequently experience psychotic-like symptoms and may demonstrate elevated psychosis vulnerability, which is associated with greater symptom severity...

Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude

The Canadian Journal of Psychiatry March 25, 2025 Noah Chisamore, Erica Kaczmarek, Zoe Doyle et al. 1 citation

Objective: To compare changes in depression, anxiety, and suicidality symptoms after a single 25 mg oral dose of psilocybin between treatment-resistant depression participants not on antidepressants at screening to participants that discontinued antidepressant medications leading up to receiving psilocybin-assisted psychotherapy (PAP). Methods: Participants (n = 27) received at least one 25 mg...

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder

The Canadian Journal of Psychiatry August 17, 2022 Joshua D. Rosenblat, Muhammad Ishrat Husain, Yena Lee et al. 58 citations

Objective Serotonergic psychedelics are re-emerging as potential novel treatments for several psychiatric disorders including major depressive disorder. The Canadian Network for Mood and Anxiety Treatments (CANMAT) convened a task force to review the evidence and provide a consensus recommendation for the clinical use of psychedelic treatments for major depressive disorder. Methods A systematic...

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur

The Canadian Journal of Psychiatry November 11, 2020 Jennifer Swainson, Alexander McGirr, Pierre Blier et al. 109 citations

OBJECTIVE: -methyl-d-aspartate (NMDA) receptor antagonist, has demonstrated rapid antidepressant effects in patients with TRD. The Canadian Network for Mood and Anxiety Treatments (CANMAT) convened a task force to review the evidence for efficacy and safety of racemic ketamine and to provide recommendations for its use in clinical practice. METHODS: A systematic review was conducted with...

The Mindful Brain and Emotion Regulation in Mood Disorders

The Canadian Journal of Psychiatry February 1, 2012 Norman A. S. Farb, Adam K. Anderson, Zindel V. Segal 361 citations

Mindfulness involves nonjudgmental attention to present-moment experience. In its therapeutic forms, mindfulness interventions promote increased tolerance of negative affect and improved well-being. However, the neural mechanisms underlying mindful mood regulation are poorly understood. Mindfulness training appears to enhance focused attention, supported by the anterior cingulate cortex and the...

Mindfulness-Based Cognitive Therapy: Theory and Practice

The Canadian Journal of Psychiatry February 1, 2012 Walter E B Sipe, Stuart J. Eisendrath 283 citations

Mindfulness-based cognitive therapy (MBCT) incorporates elements of cognitive-behavioural therapy with mindfulness-based stress reduction into an 8-session group program. Initially conceived as an intervention for relapse prevention in people with recurrent depression, it has since been applied to various psychiatric conditions. Our paper aims to briefly describe MBCT and its putative...

A Critical Review of Dissociative Trance and Possession Disorders: Etiological, Diagnostic, Therapeutic, and Nosological Issues

The Canadian Journal of Psychiatry April 1, 2011 Emmanuel H During, Fanny M Elahi, Olivier Taieb et al. 84 citations

Objective: Although the Diagnostic and Statistical Manual of Mental Disorders (DSM), Fourth Edition, acknowledges the existence of dissociative trance and possession disorders, simply named dissociative trance disorder (DTD), it asks for further studies to assess its clinical utility in the DSM-5. To answer this question, we conducted the first review of the medical literature. Method: The...

Psychotic Symptoms as a Continuum between Normality and Pathology

The Canadian Journal of Psychiatry March 1, 2009 Emmanuel Stip, Geneviève Létourneau 88 citations

This paper reviews the presence of psychotic features in the nonclinical population. The results of a literature review suggest that delusional and hallucinatory experiences are more common in the general population than we may think, and that there could well be a symptomatic continuum between people who have and people who have not been diagnosed with indisputable psychotic disorders. In the...

Does Mindfulness Meditation Improve Anxiety and Mood Symptoms? A Review of the Controlled Research

The Canadian Journal of Psychiatry April 1, 2007 Tony Toneatto, Linda Nguyen 316 citations

OBJECTIVE: To review the impact of mindfulness-based stress reduction (MBSR) on symptoms of anxiety and depression in a range of clinical populations. METHOD: Our review included any study that was published in a peer-reviewed journal, used a control group, and reported outcomes related to changes in depression and anxiety. We extracted the following key variables from each of the 15 studies...

Is Cannabis Use a Contributory Cause of Psychosis?

The Canadian Journal of Psychiatry August 1, 2006 Louisa Degenhardt, Wayne Hall

Objective: To assess whether cannabis use in adolescence and young adulthood is a contributory cause of schizophreniform psychosis in that it may precipitate psychosis in vulnerable individuals. Method: We reviewed longitudinal studies of adolescents and young adults that examined the relations between self-reported cannabis use and the risk of diagnosis with a psychosis or of reporting...

What are the Policy Implications of the Evidence on Cannabis and Psychosis?

The Canadian Journal of Psychiatry August 1, 2006 Wayne Hall, Louisa Degenhardt

Objective: To explore the implications for mental health services, for health education about the risks of cannabis use, and for public policy toward cannabis use of observational evidence that cannabis use is a contributory cause of psychosis. Method: Using comparative analyses of similar evidence for the harmful effects of alcohol, tobacco, and amphetamine use, we considered the relation...

Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study

The Canadian Journal of Psychiatry August 1, 2002 Samantha R. Gross, Sean P. Barrett, John S. Shestowsky et al. 97 citations

Objective: This study investigates the drug consumption patterns of a sample of rave attendees in the city of Montreal, Quebec, and seeks to identify the prevalence of 3,4-methylendioxymethamphetamine (MDMA) and other drug use in this population. Method: We administered a self-report questionnaire to 210 respondents. For various licit and illicit substances, participants reported their age of...

The Effects of Hypnosis on Dissociative Identity Disorder: A Reexamination of the Evidence

The Canadian Journal of Psychiatry November 1, 1999 Russell A Powell, Travis L Gee

Objective: To examine the possibility that hypnosis has significant iatrogenic effects on dissociative identity disorder (DID). Method: This paper reexamines previously published data that have been interpreted as indicating that hypnosis does not exert significant iatrogenic effects on DID. Results: The use of hypnosis is associated with differences in DID phenomenology and number of DID...

The Incidence and Significance of Perceptual Qualities in the Reported Dreams of Patients with Anorexia Nervosa

The Canadian Journal of Psychiatry September 1, 1991 Douglas H. Frayn 15 citations

The dreams of anorexic patients' were recorded using a standardized sleep questionnaire concerning the perceptual qualities and affects remembered from their dreams. The anorexic subjects consistently had less frequent dream recall, fewer dreams in colour and fewer pleasurable themes than was noted in the normal controls. Anorexics frequently saw themselves in their dreams as having a distorted...

LSD and Onset of Schizophrenia

The Canadian Journal of Psychiatry February 1, 1981 Alec Roy 7 citations

In a matched controlled study 37 chronic schizophrenics who had taken LSD preceding the onset of their illness were compared with schizophrenics who had not. There were no significant differences between the groups either on age at onset of symptoms or for age at first admission.

Mushrooms and Madness: Hallucinogenic Mushrooms and Some Psychopharmacological Implications

The Canadian Journal of Psychiatry November 1, 1980 Angus S. Mcdonald 11 citations

This article reviews the major hallucinogenic fungi both for their historical as well as neurochemical import. Despite voluminous literature on them, relatively little study has focused on psilocybin related substances that could relate to forms of psychotic illness. Some metabolic pathways are reviewed which illustrate the need for more study of indole compounds such as baeocystin.